221 related articles for article (PubMed ID: 421216)
21. Structure-activity studies of methylnitrosourea antitumor agents with reduced murine bone marrow toxicity.
Panasci LC; Fox PA; Schein PS
Cancer Res; 1977 Sep; 37(9):3321-8. PubMed ID: 141978
[No Abstract] [Full Text] [Related]
22. Antitumor activity of the novel nitrosourea S10036 in rodent tumors.
Filippeschi S; Colombo T; Bassani D; De Francesco L; Arioli P; D'Incalci M; Bartosek I; Guaitani A
Anticancer Res; 1988; 8(6):1351-4. PubMed ID: 3064716
[TBL] [Abstract][Full Text] [Related]
23. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
Finch RA; Shyam K; Penketh PG; Sartorelli AC
Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484
[TBL] [Abstract][Full Text] [Related]
24. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo activity of 1-aryl-3-(2-chloroethyl) urea derivatives as new antineoplastic agents.
Lacroix J; Gaudreault RC; Pagé M; Joly LP
Anticancer Res; 1988; 8(4):595-8. PubMed ID: 3052247
[TBL] [Abstract][Full Text] [Related]
26. Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastic activity.
Hussein A; Mioglou-Kalouptsi E; Papageorgiou A; Karapidaki I; Iakovidou-Kritsi Z; Lialiaris T; Xrysogelou E; Camoutsis C; Mourelatos D
In Vivo; 2007; 21(2):389-95. PubMed ID: 17436593
[TBL] [Abstract][Full Text] [Related]
27. Chemistry and structure-activity studies of the nitrosoureas.
Montgomery JA
Cancer Treat Rep; 1976 Jun; 60(6):651-64. PubMed ID: 954007
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and preliminary in vitro evaluation of antitumor nitrosoureido cholesterol derivatives.
Elkihel L; Gelin M; Letourneux Y
Arzneimittelforschung; 1995 Feb; 45(2):190-4. PubMed ID: 7710447
[TBL] [Abstract][Full Text] [Related]
29. Alkylphosphonium salts as a new class of antitumor agents.
Sanyal U; Chatterjee RS; Das SK; Chakraborti SK
Neoplasma; 1984; 31(2):149-55. PubMed ID: 6717684
[TBL] [Abstract][Full Text] [Related]
30. [Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry (V) (author's transl)].
Miyahara M; Kamiya S; Nakadate M; Sueyoshi S; Tanno M; Miyahara M
Eisei Shikenjo Hokoku; 1981; 99():111-3. PubMed ID: 7332796
[No Abstract] [Full Text] [Related]
31. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
Lin TS; Fischer PH; Marsh JC; Prusoff WH
Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and activities of antitumor agents.
Suami T; Machinami T; Hisamatsu T
J Med Chem; 1979 Mar; 22(3):247-50. PubMed ID: 423206
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of seleno- and thio-guanine-Pt (II) complexes and their antitumor activity in mice.
Maeda M; Abiko N; Sasaki T
Nucleic Acids Symp Ser; 1979; (6):s31-4. PubMed ID: 547237
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the mutagenic effect of certain nitrosoamides on producers of antibiotics.
Domracheva AG; Bartoshevich YE; Rapoport IA; Serebryanyi AM; Mnatsakanyan RM
Sov Genet; 1974 Mar; 7(12):1566-72. PubMed ID: 4857143
[No Abstract] [Full Text] [Related]
35. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides.
Gugova R; Topakbashian V; Lozeva S; Dimov S; Golovinsky E
Drugs Exp Clin Res; 1997; 23(2):71-5. PubMed ID: 9309382
[TBL] [Abstract][Full Text] [Related]
36. Synergistic antileukemic activity of combinations of two nitrosoureas.
Wheeler GP; Schabel FM; Trader MW
Cancer Treat Rep; 1981; 65(7-8):591-9. PubMed ID: 6454482
[TBL] [Abstract][Full Text] [Related]
37. Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
Hansch C; Leo A; Schmidt C; Jow PY; Montgomery JA
J Med Chem; 1980 Oct; 23(10):1095-101. PubMed ID: 7420354
[TBL] [Abstract][Full Text] [Related]
38. Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines.
Shyam K; Penketh PG; Loomis RH; Rose WC; Sartorelli AC
J Med Chem; 1996 Feb; 39(3):796-801. PubMed ID: 8576923
[TBL] [Abstract][Full Text] [Related]
39. The role of isocyanates in the toxicity of antitumour haloalkylnitrosoureas.
Gibson NW; Hickman JA
Biochem Pharmacol; 1982 Sep; 31(17):2795-800. PubMed ID: 7138575
[TBL] [Abstract][Full Text] [Related]
40. DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas.
Ewig RA; Kohn KW
Cancer Res; 1977 Jul; 37(7 Pt 1):2114-22. PubMed ID: 558823
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
